Health Trials

Refractory Autoimmune Diseases

1

Review clinical trials related to Refractory Autoimmune Diseases. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

A Study of Healthy Donor CD19-targeted Allogeneic CAR T Cells in Participants With Severe, Refractory Autoimmune Diseases

The purpose of this study is to determine the safety, tolerability, optimal dose, and preliminary efficacy of BMS-986515, a healthy donor (HD) allogeneic CD19-targeted CART cell product, in participants with severe, refractory autoimmune diseases.

Participants needed: 125
Trial details
Phase: Phase 1Age: 18+Biological sex: AllType: InterventionalSponsor: Juno Therapeutics, Inc., a Bristol-Myers Squibb CompanyUpdated: May 27, 2026Locations: 28
Eligibility criteria

SLE population:. [+4]

Read more